Kai Kammers

Medicine & Life Sciences

1. Radiotherapy 100%
2. Meta-Analysis 76%
3. Breast Neoplasms 58%
4. Survival 47%
5. Breast 46%
6. HIV Antibodies 46%
7. Drug Therapy 45%
8. Megakaryocytes 42%
9. Adjuvant Radiotherapy 42%
10. HIV 34%
11. Antibodies 34%
12. Whole Genome Sequencing 32%
13. Bacteriophages 31%
14. Blood Platelets 30%
15. Network Meta-Analysis 30%
16. Chemoradiotherapy 29%
17. Viral Load 29%
18. Segmental Mastectomy 28%
19. Quantitative Trait Loci 27%
20. Peptides 26%
21. Glioblastoma 26%
22. Induced Pluripotent Stem Cells 26%
23. Genome-Wide Association Study 24%
24. Proteins 24%
25. Head and Neck Neoplasms 24%
26. Proteomics 23%
27. Radio 22%
28. Epitopes 22%
29. Huntington Disease-Like 2 21%
30. Neoplasms 21%
31. Recurrence 21%
32. Genome 20%
33. lactobionic acid 20%
34. National Human Genome Research Institute (U.S.) 19%
35. Therapeutics 19%
36. National Heart, Lung, and Blood Institute (U.S.) 19%
37. RNA Helicases 18%
38. Disease-Free Survival 17%
39. Antibody Formation 17%
40. Adjuvant Chemoradiotherapy 16%
41. Lymph Nodes 16%
42. Radiation 16%
43. Heart Failure 16%
44. Bosentan 15%
45. Squamous Cell Carcinoma of Head and Neck 15%
46. Cell Tracking 15%
47. Arrhythmogenic Right Ventricular Dysplasia 15%
48. gluconic acid 15%
49. Data Science 15%
50. Data Analysis 15%